These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20736422)

  • 1. Use of psychostimulants in patients with dementia.
    Dolder CR; Davis LN; McKinsey J
    Ann Pharmacother; 2010 Oct; 44(10):1624-32. PubMed ID: 20736422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Professional consensus on the treatment of agitation, aggressive behaviour, oppositional behaviour and psychotic disturbances in dementia.
    Benoit M; Arbus C; Blanchard F; Camus V; Cerase V; Clement JP; Fremont P; Guerin O; Hazif Thomas C; Jeanblanc F; Lafont C; Moreaud O; Pedra M; Poncet M; Richard Harston S; Rigaud AS; Sotto Martin ME; Touchon J; Vellas B; Fitten LJ; Robert PH
    J Nutr Health Aging; 2006; 10(5):410-5. PubMed ID: 17066213
    [No Abstract]   [Full Text] [Related]  

  • 3. Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication.
    Forester B; Vanelli M; Hyde J; Perez R; Ahokpossi C; Sribney W; Adkison L
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):209-17. PubMed ID: 17996660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The course of psychiatric and behavioral symptoms and the use of psychotropic medication in patients with dementia in Norwegian nursing homes--a 12-month follow-up study.
    Selbaek G; Kirkevold Ø; Engedal K
    Am J Geriatr Psychiatry; 2008 Jul; 16(7):528-36. PubMed ID: 18591573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychostimulants: new concepts for palliative care from the modafinil experience?
    Caraceni A; Simonetti F
    J Pain Symptom Manage; 2004 Aug; 28(2):97-9. PubMed ID: 15276188
    [No Abstract]   [Full Text] [Related]  

  • 6. Modafinil: a second look. Confirmed efficacy in narcolepsy.
    Prescrire Int; 1999 Feb; 8(39):5-7. PubMed ID: 10557564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic management of the symptoms of dementia.
    McDonald WM; Krishnan KR
    Am Fam Physician; 1990 Jul; 42(1):123-32. PubMed ID: 2195854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease mongering and excessive daytime sleepiness.
    Brown SR
    Am Fam Physician; 2009 Oct; 80(8):775. PubMed ID: 19835338
    [No Abstract]   [Full Text] [Related]  

  • 9. Risperidone for the treatment of behavioral and psychological symptoms of dementia.
    Tune LE
    J Clin Psychiatry; 2001; 62 Suppl 21():29-32. PubMed ID: 11584986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why choose modafinil for excessive daytime sleepiness?
    Tobin ML
    Issues Ment Health Nurs; 2007 Mar; 28(3):313-7. PubMed ID: 17454283
    [No Abstract]   [Full Text] [Related]  

  • 11. An update on the pharmacotherapy of excessive daytime sleepiness and cataplexy.
    Mignot E
    Sleep Med Rev; 2004 Oct; 8(5):333-8. PubMed ID: 15336234
    [No Abstract]   [Full Text] [Related]  

  • 12. Methylphenidate use for the management of opioid-induced sedation.
    Westberg J; Gobel BH
    Clin J Oncol Nurs; 2004 Apr; 8(2):203-5. PubMed ID: 15108423
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacotherapy for excessive daytime sleepiness.
    Banerjee D; Vitiello MV; Grunstein RR
    Sleep Med Rev; 2004 Oct; 8(5):339-54. PubMed ID: 15336235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An open study of modafinil for the treatment of daytime somnolence and fatigue in primary biliary cirrhosis.
    Jones DE; Newton JL
    Aliment Pharmacol Ther; 2007 Feb; 25(4):471-6. PubMed ID: 17270003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modafinil for the treatment of hypersomnia associated with myotonic muscular dystrophy in adults: a multicenter, prospective, randomized, double-blind, placebo-controlled, 4-week trial.
    Orlikowski D; Chevret S; Quera-Salva MA; Laforêt P; Lofaso F; Verschueren A; Pouget J; Eymard B; Annane D
    Clin Ther; 2009 Aug; 31(8):1765-73. PubMed ID: 19808135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmental correlates of neuropsychiatric symptoms in nursing home patients with dementia.
    Zuidema SU; de Jonghe JF; Verhey FR; Koopmans RT
    Int J Geriatr Psychiatry; 2010 Jan; 25(1):14-22. PubMed ID: 19517419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial.
    Högl B; Saletu M; Brandauer E; Glatzl S; Frauscher B; Seppi K; Ulmer H; Wenning G; Poewe W
    Sleep; 2002 Dec; 25(8):905-9. PubMed ID: 12489899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of agitation in older persons with dementia. The Expert Concensus Panel for agitation in dementia.
    Postgrad Med; 1998 Apr; Spec No():1-88. PubMed ID: 9585819
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antipsychotic drug therapy for patients with behavioral and psychological symptoms of dementia(BPSD)].
    Kudo T
    Seishin Shinkeigaku Zasshi; 2007; 109(7):657-63. PubMed ID: 17969953
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.